177 related articles for article (PubMed ID: 22285285)
1. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?
Johnson MJ; Abernethy AP; Currow DC
J Pain Symptom Manage; 2012 Mar; 43(3):614-24. PubMed ID: 22285285
[TBL] [Abstract][Full Text] [Related]
2. Update on combined modalities for the management of breathlessness.
Clemens KE; Faust M; Bruera E
Curr Opin Support Palliat Care; 2012 Jun; 6(2):163-7. PubMed ID: 22469671
[TBL] [Abstract][Full Text] [Related]
3. The evidence base for oxygen for chronic refractory breathlessness: issues, gaps, and a future work plan.
Johnson MJ; Abernethy AP; Currow DC
J Pain Symptom Manage; 2013 Apr; 45(4):763-75. PubMed ID: 23017616
[TBL] [Abstract][Full Text] [Related]
4. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
Varkey B
Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
[TBL] [Abstract][Full Text] [Related]
5. [Management of refractory breathlessness in patients with advanced disease].
Bausewein C
Internist (Berl); 2016 Oct; 57(10):978-982. PubMed ID: 27587195
[TBL] [Abstract][Full Text] [Related]
6. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
[TBL] [Abstract][Full Text] [Related]
7. Advances in the pharmacological management of breathlessness.
Currow DC; Ward AM; Abernethy AP
Curr Opin Support Palliat Care; 2009 Jun; 3(2):103-6. PubMed ID: 19333124
[TBL] [Abstract][Full Text] [Related]
8. Opioids for refractory dyspnea.
Mahler DA
Expert Rev Respir Med; 2013 Apr; 7(2):123-34; quiz 135. PubMed ID: 23547989
[TBL] [Abstract][Full Text] [Related]
9. The role of inhaled opioids and furosemide for the treatment of dyspnea.
Kallet RH
Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological therapy of refractory dyspnoea : a systematic literature review].
Simon ST; Köskeroglu P; Bausewein C
Schmerz; 2012 Sep; 26(5):515-22. PubMed ID: 22956077
[TBL] [Abstract][Full Text] [Related]
11. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review.
Vargas-Bermúdez A; Cardenal F; Porta-Sales J
J Pain Palliat Care Pharmacother; 2015; 29(4):341-52. PubMed ID: 26523974
[TBL] [Abstract][Full Text] [Related]
12. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
14. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
[TBL] [Abstract][Full Text] [Related]
15. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
16. Opioids for chronic refractory breathlessness: right patient, right route?
Currow DC; Ekstrom M; Abernethy AP
Drugs; 2014 Jan; 74(1):1-6. PubMed ID: 24327297
[TBL] [Abstract][Full Text] [Related]
17. Putting evidence into practice: evidence-based interventions for cancer-related dyspnea.
DiSalvo WM; Joyce MM; Tyson LB; Culkin AE; Mackay K
Clin J Oncol Nurs; 2008 Apr; 12(2):341-52. PubMed ID: 18390468
[TBL] [Abstract][Full Text] [Related]
18. Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea.
Ross DD; Alexander CS
Am Fam Physician; 2001 Sep; 64(6):1019-26. PubMed ID: 11578023
[TBL] [Abstract][Full Text] [Related]
19. Use of short-acting opioids in the management of breathlessness: an evidence-based review.
Hui D; Bruera E
Curr Opin Support Palliat Care; 2020 Sep; 14(3):167-176. PubMed ID: 32701856
[TBL] [Abstract][Full Text] [Related]
20. Opioids, Exertion, and Dyspnea: A Review of the Evidence.
Johnson MJ; Hui D; Currow DC
Am J Hosp Palliat Care; 2016 Mar; 33(2):194-200. PubMed ID: 25294225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
